The drug pipeline is full of new medications that may be more effective but may also be more expensive than existing treatments. Although they could significantly improve a benefits plan member’s health, they could also render a plan unaffordable. “Because drugs represent a significant portion of group insurance plan costs, plan sponsors are concerned about […]
The coronavirus pandemic and the changing environment have impacted pharmaceutical manufacturer-sponsored patient support programs. Manufacturers offer patient support programs to help individuals access their medication and navigate the health-care system, according to Sandra Anderson, senior vice-president of commercialization and strategy at Innomar Strategies, speaking during a session at Benefits Canada‘s Face to Face in Drug […]
A growing number of organizations are moving beyond compliance to foster diversity, equity and inclusion in their workplaces. According to research, companies that have embraced a DEI strategy improved their bottom line with a 53 per cent return on equity, a 42 per cent return on sales, in addition to being 70 per cent more […]
The coronavirus pandemic is demonstrating that pharmacists are a key health-care provider, with one study finding nearly 75 per cent of pharmacists have had patients who sought care at the pharmacy because they were afraid of going to any other health-care setting. A panel during Benefits Canada‘s Face to Face in Drug Plan Management Forum in […]
One in five Canadians will experience a mental illness in their lifetime and by age 40 about 50 per cent of the population will have or have had one. Mental illness includes conditions such as depression, schizophrenia or bipolar disorder, which “can really affect the ability of an individual to function,” said Nida Mian, senior […]
In 2020, members of the Canadian Life and Health Insurance Association spent $650 million on drugs for rare diseases for more than 13,000 patients. Rare diseases affect one in 12 Canadians and between 6,000 and 8,000 rare diseases are known globally. In addition, roughly 80 per cent of these diseases occur in children and only […]
A story on the Toronto-Dominion Bank’s enhancement to its benefits offerings in 2022 with expanded family planning coverage took the top spot over the past week on BenefitsCanada.com. Here are the five most popular news stories of the week: 1. TD expanding fertility treatment coverage, bereavement policy 2. N.S. Pension Services Corp. appoints new CIO 3. 82% of Canadian workers think […]
About three-quarters (78 per cent) of U.S. employers said they’re more focused on the quality of health care over cost management when making decisions about their benefits plan amid the current war for talent acquisition and retention, according to a new survey by Artemis Health Inc. The survey, which polled more than 300 U.S. human […]
The Toronto-Dominion Bank is enhancing its benefits offerings in 2022 with expanded family planning coverage. The bank’s benefits program is now covering fertility and reproductive treatments and offering support for surrogacy or donor costs and adoption costs, with a $20,000 lifetime maximum for each benefit, says Melanie Burns, TD’s senior vice-president of human resources and talent […]
Toronto-based virtual-care platform Maple Corp. is acquiring Wello, a Calgary-based virtual health-care brand. Wello, which was founded in 2017, is a wholly-owned subsidiary of Coril Holdings Ltd. and provides access to virtual primary medical care to employees of more than 350 companies across Canada. Maple was founded in 2015 and is billed as “Canada’s largest […]